A Nested Case–Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

PLoS Medicine

Volumn 13, Issue 4, 2016, Pages

  Murphy, Neil ^a   Cross, Amanda J ^a   Abubakar, Mustapha ^b   Jenab, Mazda ^c   Aleksandrova, Krasimira ^d   Boutron Ruault, Marie Christine ^e,f,g   Dossus, Laure ^e,f,g   Racine, Antoine ^e,f,g   Kühn, Tilman ^h   Katzke, Verena A ^h   Tjønneland, Anne ⁱ   Petersen, Kristina E N ⁱ   Overvad, Kim ^j   Quirós, J Ramón ^k   Jakszyn, Paula ^l   Molina Montes, Esther ^m,n   Dorronsoro, Miren ⁿ   Huerta, José María ^n,o   Barricarte, Aurelio ^n,p   Khaw, Kay Tee ^q   Wareham, Nick ^r   Travis, Ruth C ^s   Trichopoulou, Antonia ^t,u,v   Lagiou, Pagona ^u,v,w   Trichopoulos, Dimitrios ^t,v,w   Masala, Giovanna ^x   Krogh, Vittorio ^y   Tumino, Rosario ^z   Vineis, Paolo ^a,aa   Panico, Salvatore ^ab   Bueno de Mesquita, H Bas ^a,ac,ad,ae   Siersema, Peter D ^ad   Peeters, Petra H ^ad   Ohlsson, Bodil ^af   Ericson, Ulrika ^af   Palmqvist, Richard ^ag   Nyström, Hanna ^ag   Weiderpass, Elisabete ^ah,ai,aj,ak   Skeie, Guri ^ah   Freisling, Heinz ^c   Kong, So Yeon ^c   Tsilidis, Kostas ^a,al   Muller, David C ^c   Riboli, Elio ^a   Gunter, Marc J ^a,c   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e INSERM   (France)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j AARHUS UNIVERSITY   (Denmark)

^k PUBLIC HEALTH DIRECTORATE   (Spain)

^l CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^m ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

ⁿ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^o DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^p INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t HELLENIC HEALTH FOUNDATION   (Greece)

^u UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^v BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^w HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^x CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^y NATIONAL CANCER INSTITUTE   (Italy)

^z Civile MPArezzo Hospital   (Italy)

^aa HuGeF Foundation   (Italy)

^ab UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ac NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ad UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ae UNIVERSITY OF MALAYA   (Malaysia)

^af LUND UNIVERSITY HOSPITAL   (Sweden)

^ag UMEÅ UNIVERSITY   (Sweden)

^ah UNIVERSITY OF TROMSØ   (Norway)

^ai CANCER REGISTRY OF NORWAY   (Norway)

^aj KAROLINSKA INSTITUTE   (Sweden)

^ak FOLKHÄLSAN RESEARCH CENTER   (Finland)

^al UNIVERSITY OF IOANNINA   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; BIOLOGICAL MARKER;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; QUESTIONNAIRE; WAIST CIRCUMFERENCE; BLOOD; BODY SIZE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EUROPE; HEALTH STATUS; HYPERINSULINISM; INCIDENCE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBESITY, METABOLICALLY BENIGN; ODDS RATIO; PROSPECTIVE STUDY; PROTECTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADIPOSITY; BIOMARKERS; BODY MASS INDEX; BODY SIZE; C-PEPTIDE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HEALTH STATUS; HUMANS; HYPERINSULINISM; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OBESITY, METABOLICALLY BENIGN; ODDS RATIO; PHENOTYPE; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84964777727     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001988     Document Type: Article

References (28)

1. Larsson SC, Wolk A, (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr86: 556–565. 17823417
2. Moghaddam AA, Woodward M, Huxley R, (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev16: 2533–2547. 18086756
3. Vazquez G, Duval S, Jacobs DR, Silventoinen K, (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev29: 115–128. 17494056
4. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M, (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet371: 569–578. doi: 10.1016/S0140-6736(08)60269-X18280327
5. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst98: 920–931. 16818856
6. Giovannucci E, (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr86: 836S–842S.
7. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, et al. (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res68: 329–337. doi: 10.1158/0008-5472.CAN-07-294618172327
8. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, et al. (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst91: 1147–1154. 10393723
9. Bonser AM, Garcia-Webb P, Harrison LC, (1984) C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci19: 297–352. doi: 10.3109/104083684091657666373142
10. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst92: 1592–1600. 11018095
11. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, et al. (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer121: 368–376. doi: 10.1002/ijc.2269717372899
12. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, et al. (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst96: 546–553. 15069117
13. Gunter MJ, Xie X, Xue X, Kabat GC, Rohan TE, et al. (2015) Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res75: 270–274. doi: 10.1158/0008-5472.CAN-14-231725593034
14. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, et al. (2012) Incident cardiovascular disease events in metabolically benign obese individuals. Obesity20: 651–659. doi: 10.1038/oby.2011.24321799477
15. Meigs JB, Wilson PWF, Fox CS, Vasan RS, Nathan DM, et al. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab91: 2906–2912. 16735483
16. Bo S, Musso G, Gambino R, Villois P, Gentile L, et al. (2012) Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort. Am J Clin Nutr96: 962–969. doi: 10.3945/ajcn.112.04000623034958
17. Riboli E, Kaaks R, (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol26: S6. 9126529
18. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr5: 1113–1124. 12639222
19. Rinaldi S, Rohrmann S, Jenab M, Biessy C, Sieri S, Palli D, et al. (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev17: 3108–3115. doi: 10.1158/1055-9965.EPI-08-049518990751
20. Alberti KGM, Zimmet P, Shaw J, (2005) The metabolic syndrome—a new worldwide definition. Lancet366: 1059–1062. 16182882
21. Dvorak RV, DeNino WF, Ades PA, Poehlman ET, (1999) Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes48: 2210–2214. 10535456
22. Hyun YJ, Koh SJ, Chae JS, Kim JY, Kim OY, et al. (2008) Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity16: 784–789. doi: 10.1038/oby.2007.12718239579
23. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, et al. (2007) Normal-weight obese syndrome: early inflammation?Am J Clin Nutr85: 40–45. 17209175
24. Yun KE, Chang Y, Jung HS, Kim CW, Kwon MJ, et al. (2013) Impact of body mass index on the risk of colorectal adenoma in a metabolically healthy population. Cancer Res73: 4020–4027. doi: 10.1158/0008-5472.CAN-12-347723687341
25. Aleksandrova K, Boeing H, Jenab M, Bas Bueno-de-Mesquita H, Jansen E, et al. (2011) Metabolic syndrome and risks of colon and rectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Cancer Prev Res4: 1873–1883.
26. Aleksandrova K, Nimptsch KF, Pischon T, (2013) Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep2: 1–9. 23396857
27. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, et al. (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev14: 850–855. 15824155
28. Kitahara CM, Berndt SI, de Gonzalez AB, Coleman HG, Schoen RE, et al. (2013) Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. J Clin Oncol31: 2450–2459. doi: 10.1200/JCO.2012.48.469123715565